Marín A, Eseverri J L, Botey J
Unidad de Alergología e Inmunología Clínica Pediátrica, Hospital Infantil Valle de Hebrón, Barcelona.
Allergol Immunopathol (Madr). 1998 May-Jun;26(3):114-9.
The prevalence of atopic dermatitis and other allergic diseases is increasing in industrialized countries. Today we know that atopy is conditioned genetically, but the development of the atopic phenotype requires environmental factors. It is believed that the genetic factors have not changed and that the increased prevalence is due to the increase in exposure to allergenic and non-specific environmental factors. The potential for sensitization is greater in the early years of life, so it is necessary to reduce harmful environmental exposure at these ages. Atopic clinical manifestations develop sequentially, in many cases beginning with atopic dermatitis in the early months of life. We know that children with atopic dermatitis present non-specific bronchial hyperreactivity (58 to 82%), which is a risk factor for the later development of asthma. The presence of specific bronchial hyperreactivity for mites in atopic dermatitis with mite sensitization also has been described, and it has been demonstrated that signs of eczema can develop or become exacerbated by airway exposure during bronchial challenge tests. The evolution from atopic dermatitis to asthma is a possibility that must be kept in mind. Patients should be followed-up and study of hyperreactivity and sensitization to allergens should be carried out in order to prevent the development of clinical symptoms. Prevention should include pneumoallergens, food allergens, and non-specific environmental risk factors, such as parental smoking (particularly mothers), pollution inside and outside the home, etc. Prevention is particularly important in children at risk of allergy, as determined by a family history among first-degree relatives, as well as the presence of atopic dermatitis, particularly of early onset, because these patient are most at risk of developing bronchial asthma in later years. At present, pharmacological prevention is being studied, without overlooking environmental prevention, in children at high risk of atopic disease for the purpose of preventing chronic inflammations that will condition their future as adults. In our daily clinical experience, atopic dermatitis is responsible for 8% of visits to a pediatric allergology unit. We emphasize that 62.5% of our patients with dermatitis are referred when they already have bronchial asthma, which represents an important delay in diagnosis with respect to the onset of symptoms.
在工业化国家,特应性皮炎和其他过敏性疾病的患病率正在上升。如今我们知道特应性由遗传决定,但特应性表型的发展需要环境因素。据信遗传因素并未改变,患病率增加是由于接触变应原和非特异性环境因素的增加。在生命早期致敏的可能性更大,因此有必要在这些年龄段减少有害的环境暴露。特应性临床表现依次出现,在许多情况下始于生命最初几个月的特应性皮炎。我们知道,患有特应性皮炎的儿童存在非特异性支气管高反应性(58%至82%),这是日后发生哮喘的一个危险因素。在对螨虫致敏的特应性皮炎中,也有对螨虫的特异性支气管高反应性的描述,并且已经证明在支气管激发试验期间,气道暴露可使湿疹症状加重或出现。必须牢记特应性皮炎发展为哮喘的可能性。应跟踪患者,并进行高反应性和对过敏原致敏的研究,以预防临床症状的出现。预防措施应包括吸入性变应原、食物变应原以及非特异性环境危险因素,如父母吸烟(尤其是母亲)、家庭内外的污染等。对于有过敏风险的儿童,预防尤为重要,过敏风险由一级亲属的家族病史以及特应性皮炎的存在(尤其是早发型)来确定,因为这些患者在晚年发生支气管哮喘的风险最高。目前,正在对高危特应性疾病儿童进行药物预防研究,同时也不忽视环境预防,目的是预防将影响其成年后生活的慢性炎症。在我们的日常临床经验中,特应性皮炎占儿科过敏科门诊量的8%。我们强调,62.5%的皮炎患者在已患有支气管哮喘时才前来就诊,这相对于症状出现而言存在重要的诊断延迟。